Venezuelan Equine Encephalitis Virus Envelope Glycoprotein (VEEV Envelope Glycoprotein)

The Venezuelan equine encephalitis virus (VEEV) envelope glycoproteins, primarily E1 and E2, are critical structural proteins embedded in the viral membrane. These glycoproteins play essential roles in viral entry, host range determination, virulence, immune evasion, and vector specificity. The E2 protein contains domains responsible for receptor binding. Specific mutations within the envelope genes—especially a small number within the E2 gene—can convert an enzootic (rodent-adapted) strain into an epizootic (equine-amplifying) strain capable of causing outbreaks among horses and humans. Attenuated live vaccines exploit mutations within these genes, balancing safety with immunogenicity. The surface-exposed nature of the envelope glycoproteins makes them primary targets for neutralizing antibodies. Antigenic epitopes that distinguish enzootic from epizootic subtypes reside on these proteins—mainly on E2—which also defines serotype specificity used for diagnostics or vaccine design purposes.

Other names

VEEV E1VEEV E2E1 glycoproteinE2 glycoproteinVEEV PE2

Target for neutralizing antibodies; mutations can be exploited for vaccine development.